Brand-new biotech drug for diabetic foot ulcers

February 1998

There's a brand-new biotech drug for diabetic foot ulcers...called Regranex (becaplermin gel).

It contains a platelet-derived growth factor to stimulate the growth of new tissue...resulting in a modest increase in healing.

This is important. Diabetic foot ulcers are extremely hard to treat...and can lead to serious infections and amputation.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote